Prognostic implications of preoperative, postoperative, and dynamic changes of alpha-fetoprotein and des-gamma (γ)-carboxy prothrombin expression pattern for hepatocellular carcinoma after hepatic resection: a multicenter observational study

被引:1
|
作者
Tang, Shi-Chuan [1 ,2 ,3 ]
Wu, Ye-Ye [4 ]
Lin, Zhi-Wen [3 ]
Chen, Qing-Jing [1 ,2 ,3 ]
Luo, Cong [5 ]
Li, Yun-Tong [6 ]
Fu, Jun [3 ]
Zheng, Li-Fang [3 ]
You, Peng-Hui [7 ]
You, Song [3 ]
You, Wu-Yi [8 ]
Lin, Ke-Can [3 ]
Zhou, Wei-Ping [9 ]
Lin, Kong-Ying [1 ,2 ,3 ]
Zeng, Yong-Yi [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Med Coll, Clin 1, Fuzhou, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[3] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[4] Second Mil Med Univ, Navy Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surgery2, Shanghai, Peoples R China
[5] Peoples Hosp Zizhong Cty, Dept Hepatopancreatobiliary Surg, Zizhong, Peoples R China
[6] Xiamen Univ, Dept Hepatobiliary Surg, ZhongShan Hosp, Xiamen, Peoples R China
[7] Fujian Med Univ, Bioinformat Sample Bank, Biobank Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[8] Fujian Med Univ, Dept Radiat, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[9] Navy Med Univ, Mil Med Univ 2, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; alpha-fetoprotein; des-gamma (gamma)-carboxy prothrombin; resection; prognosis; CARBOXY PROTHROMBIN; LIVER-TRANSPLANTATION; TUMOR-MARKERS; DIAGNOSIS; RECURRENCE; SURVIVAL; ABLATION; MODEL; HCC;
D O I
10.3389/fonc.2024.1425292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The utility of pre- and post-operative alpha-fetoprotein (AFP) and des-gamma (gamma)-carboxy prothrombin (DCP) expression patterns and their dynamic changes as predictors of the outcome of hepatic resection for hepatocellular carcinoma (HCC) has yet to be well elucidated. Methods: From a multicenter database, AFP and DCP data during the week prior to surgery and the first post-discharge outpatient visit (within 1-2 months after surgery) were collected from patients with HCC who underwent hepatectomy. AFP-DCP expression patterns were categorized according to the number of positive tumor markers (AFP >= 20ng/mL, DCP >= 40mAU/mL), including double-negative, single-positive, and double-positive. Changes in the AFP-DCP expression patterns were delineated based on variations in the number of positive tumor markers when comparing pre- and post-operative patterns. Results: Preoperatively, 53 patients (8.3%), 337 patients (52.8%), and 248 patients (38.9%) exhibited double-negative, single-positive, and double-positive AFP-DCP expression patterns, respectively. Postoperatively, 463 patients (72.6%), 130 patients (20.4%), and 45 patients (7.0%) showed double-negative, single-positive, and double-positive AFP-DCP expression patterns, respectively. Survival analysis showed a progressive decrease in recurrence-free (RFS) and overall survival (OS) as the number of postoperative positive tumor markers increased (both P < 0.001). Multivariate analysis showed that postoperative AFP-DCP expression pattern, but not preoperative AFP-DCP expression pattern, was an independent risk factor for RFS and OS. Further analysis showed that for patients with positive preoperative markers, prognosis gradually improves as positive markers decrease postoperatively. In particular, when all postoperative markers turned negative, the prognosis was consistent with that of preoperative double-negative patients, regardless of the initial number of positive markers. Conclusions: AFP-DCP expression patterns, particularly postoperative patterns, serve as vital sources of information for prognostic evaluation following hepatectomy for HCC. Moreover, changes in AFP-DCP expression patterns from pre- to post-operation enable dynamic prognostic risk stratification postoperatively, aiding the development of individualized follow-up strategies.
引用
收藏
页数:14
相关论文
共 29 条
  • [1] Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma
    Shimada, M
    Takenaka, K
    Fujiwara, Y
    Gion, T
    Kajiyama, K
    Maeda, T
    Shirabe, K
    Sugimachi, K
    CANCER, 1996, 78 (10) : 2094 - 2100
  • [2] Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study
    Saegusa, Yoshitaka
    Imaoka, Yuki
    Ohira, Masahiro
    Kobayashi, Tsuyoshi
    Honmyo, Naruhiko
    Hamaoka, Michinori
    Onoe, Takashi
    Takei, Daisuke
    Oishi, Koichi
    Abe, Tomoyuki
    Nakayama, Toshihiro
    Akabane, Miho
    Sasaki, Kazunari
    Ohdan, Hideki
    JOURNAL OF GASTROINTESTINAL SURGERY, 2025, 29 (04)
  • [3] Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma
    Nakao, A
    Taniguchi, K
    Inoue, S
    Harada, A
    Nonami, T
    Watanabe, K
    Takagi, H
    SEMINARS IN SURGICAL ONCOLOGY, 1996, 12 (03): : 160 - 163
  • [4] Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy
    Zhang, Teng
    Li, Wengang
    Chen, Qian
    He, Weiping
    Sun, Jing
    Li, Dong
    Wang, Quan
    Duan, Xuezhang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma
    Aoyagi, Y
    Oguro, M
    Yanagi, M
    Mita, Y
    Suda, T
    Suzuki, Y
    Hata, K
    Ichii, K
    Asakura, H
    CANCER, 1996, 77 (09) : 1781 - 1786
  • [6] Half-Life of Serum Alpha-Fetoprotein An Early Prognostic Index of Recurrence and Survival After Hepatic Resection for Hepatocellular Carcinoma
    Shim, Ju Hyun
    Han, Seungbong
    Lee, Young-Joo
    Lee, Sung-Gyu
    Kim, Kang Mo
    Lim, Young-Suk
    Chung, Young-Hwa
    Lee, Yung Sang
    Lee, Han Chu
    ANNALS OF SURGERY, 2013, 257 (04) : 708 - 717
  • [7] The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages
    Nagahara, Takakazu
    Sugihara, Takaaki
    Kihara, Takuya
    Ikeda, Suguru
    Hoshino, Yoshiki
    Matsuki, Yukako
    Sakaguchi, Takuki
    Kurumi, Hiroki
    Onoyama, Takumi
    Takata, Tomoaki
    Matono, Tomomitsu
    Yamaguchi, Naoyuki
    Isomoto, Hajime
    CANCERS, 2023, 15 (02)
  • [8] Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
    Nunez, Kelley G.
    Sandow, Tyler
    Fort, Daniel
    Patel, Jai
    Hibino, Mina
    Carmody, Ian
    Cohen, Ari J.
    Thevenot, Paul
    CANCERS, 2021, 13 (19)
  • [9] Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma
    Lim, Tae Seop
    Rhee, Hyungjin
    Kim, Gyoung Min
    Kim, Seung Up
    Kim, Beom Kyung
    Park, Jun Yong
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Choi, Jin-Young
    Kim, Do Young
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (08) : 1194 - 1200
  • [10] Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma
    Lee, Myoung Ha
    Kim, Seung Up
    Kim, Do Young
    Ahn, Sang Hoon
    Choi, Eun Hee
    Lee, Kwang Hun
    Lee, Do Yun
    Seong, Jinsil
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 313 - 322